Clinical Trial
doi: 10.1007/BF00441919.
Clinical trials of sulfonated immunoglobulin preparation for intravenous administration. II. Adverse reactions
- PMID: 6164555
- DOI: 10.1007/BF00441919
Item in Clipboard
Clinical Trial
Clinical trials of sulfonated immunoglobulin preparation for intravenous administration. II. Adverse reactions
Eur J Pediatr.
1981 May.
No abstract available
Similar articles
-
Consensus on IVIG.Lancet. 1990 Aug 25;336(8713):470-2. Lancet. 1990. PMID: 1974993 Review. No abstract available.
-
Clinical trial of sulfonated immunoglobulin preparation for intravenous administration. I. Replacement therapy for primary immunodeficiency syndromes.Eur J Pediatr. 1981 May;136(2):159-65. doi: 10.1007/BF00441918. Eur J Pediatr. 1981. PMID: 6164554 Clinical Trial.
-
Behaviour of serum immunoglobulins during and after intravenous administration of gamma-globulins in patients with antibody deficiency syndrome.Boll Ist Sieroter Milan. 1974;53(1):suppl:268. Boll Ist Sieroter Milan. 1974. PMID: 4136556 No abstract available.
-
Uses and limitations of gammaglobulin therapy (literature review).Paediatr Indones. 1974 Sep-Oct;14(9-10):174-84. doi: 10.14238/pi14.9-10.1974.174-84. Paediatr Indones. 1974. PMID: 4142072 No abstract available.
-
The use of intravenous immunoglobulins: recommendations of a consensus conference of the working group of immunology of the Italian Society of Pediatrics.Ann Allergy. 1989 Apr;62(4):362-7. Ann Allergy. 1989. PMID: 2495747 Review. No abstract available.
Cited by
-
1040 prophylactic infusions with an unmodified intravenous immunoglobulin product causing few side-effects in patients with antibody deficiency syndromes.Infection. 1985 May-Jun;13(3):102-10. doi: 10.1007/BF01642867. Infection. 1985. PMID: 4030106
-
A prospective controlled crossover trial of a new heat-treated intravenous immunoglobulin.Clin Exp Immunol. 1995 Jan;99(1):10-5. doi: 10.1111/j.1365-2249.1995.tb03465.x. Clin Exp Immunol. 1995. PMID: 7813100 Free PMC article. Clinical Trial.
-
Aseptic meningitis associated with high dose intravenous immunoglobulin therapy.J Neurol Neurosurg Psychiatry. 1991 Mar;54(3):275-6. doi: 10.1136/jnnp.54.3.275. J Neurol Neurosurg Psychiatry. 1991. PMID: 2030359 Free PMC article.
-
Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis.J Neurol Neurosurg Psychiatry. 1993 Jul;56(7):830-1. doi: 10.1136/jnnp.56.7.830-a. J Neurol Neurosurg Psychiatry. 1993. PMID: 8380010 Free PMC article. No abstract available.
-
Adverse Effects of Immunoglobulin Therapy.Front Immunol. 2018 Jun 8;9:1299. doi: 10.3389/fimmu.2018.01299. eCollection 2018. Front Immunol. 2018. PMID: 29951056 Free PMC article. Review.